HomeHEMO • LON
add
Hemogenyx Pharmaceuticals PLC
Previous close
GBX 0.93
Day range
GBX 0.87 - GBX 1.10
Year range
GBX 0.84 - GBX 7.13
Market cap
19.50M GBP
Avg Volume
17.11M
P/E ratio
-
Dividend yield
-
Primary exchange
LON
Financials
Income Statement
Revenue
Net income
| (GBP) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.35M | -36.17% |
Net income | -1.41M | 34.90% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.29M | 37.31% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (GBP) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.64M | -46.75% |
Total assets | 6.12M | -15.33% |
Total liabilities | 3.09M | -13.94% |
Total equity | 3.02M | — |
Shares outstanding | 1.34B | — |
Price to book | ∞ | — |
Return on assets | -55.00% | — |
Return on capital | -57.92% | — |
Cash Flow
Net change in cash
| (GBP) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -1.41M | 34.90% |
Cash from operations | -1.18M | 33.64% |
Cash from investing | 8.66K | -58.28% |
Cash from financing | 1.42M | -21.03% |
Net change in cash | 197.58K | -28.42% |
Free cash flow | -724.45K | 39.36% |
About
Founded
2013
Website
Employees
17
